Drug Des Devel Ther 19:56455652 Wang Y, Lan B, Zhang S, Mu Y, Mi J, Yu J et al (2025) Dionysus or apollo, skeletal muscle mass changes in type 2 diabetes with sarcopenia receiving GLP-1 receptor agonist: systematic review and meta-analysis
Ultimately, the decision lies in your hands, but it's important to consider all aspects before making a choice
Selection should match goals, tolerance, access, and budget
Each bottle of Codeage GLP-1 Probiotic+ comes with 90 servings for a 3-month supply
Medicare Part D is statutorily prohibited from covering medications prescribed solely for weight loss, which means most seniors who don't have type 2 diabetes, established cardiovascular disease, or moderate-to-severe sleep apnea are paying out of pocket and the manufacturer copay cards advertised everywhere (the "$25/month Wegovy" or "$25/month Zepbound" offers) are explicitly off-limits to Medicare, Medicaid, TRICARE, and VA beneficiaries under federal anti-kickback law
Data from participants without events of interest were censored at the end of their in-trial period